Pegylated interferon-α2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B

被引：1

作者：

ter Borg, MRNJ ^{[1
]}

Janssen, HLA ^{[1
]}

机构：

[1] Erasmus MC, NL-3015 GD Rotterdam, Netherlands

来源：

ANNALS OF INTERNAL MEDICINE | 2005年 / 143卷 / 05期

关键词：

D O I：

10.7326/0003-4819-143-5-200509060-00018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：391 / 391

页数：1

共 50 条

[1] The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon
Cooksley, G
[J]. JOURNAL OF HEPATOLOGY, 2003, 39 : S143 - S145
[2] Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype
Sonneveld, Milan J.
Rijckborst, Vincent
Cakaloglu, Yilmaz
Simon, Krzysztof
Heathcote, E. Jenny
Tabak, Fehmi
Mach, Tomasz
Boucher, Charles A. B.
Hansen, Bettina E.
Zeuzem, Stefan
Janssen, Harry L. A.
[J]. ANTIVIRAL THERAPY, 2012, 17 (01) : 9 - 17
[3] Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B
Mihm, Ulrike
Chan, Henry Lik-Yuen
Zeuzem, Stefan
Chim, Angel Mei-Ling
Hui, Alex Yui
Wong, Vincent Wai-Sun
Sung, Joseph Jao-Yiu
Herrmann, Eva
[J]. ANTIVIRAL THERAPY, 2008, 13 (08) : 1029 - 1037
[4] Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders
Schiff, ER
Dienstag, JL
Karayalcin, S
Grimm, IS
Perrillo, RP
Husa, P
de Man, RA
Goodman, Z
Condreay, LD
Crowther, LM
Woessner, MA
McPhillips, PJ
Brown, NA
[J]. JOURNAL OF HEPATOLOGY, 2003, 38 (06) : 818 - 826
[5] Higher efficacy of pegylated interferon-α2b add-on therapy in hepatitis B envelope antigen-positive chronic hepatitis B patients on tenofovir monotherapy
Jindal, Ankur
Vyas, Ashish Kumar
Kumar, Devesh
Kumar, Guresh
Sharma, Manoj Kumar
Sarin, Shiv Kumar
[J]. HEPATOLOGY RESEARCH, 2018, 48 (06) : 451 - 458
[6] Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B:: A randomized study
Liu, CJ
Lai, MY
Chao, YC
Liao, LY
Yang, SS
Hsiao, TJ
Hsieh, TY
Lin, CL
Hu, JT
Chen, CL
Chen, PJ
Kao, JH
Chen, DS
[J]. HEPATOLOGY, 2006, 43 (04) : 742 - 749
[7] Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B
Enomoto, Masaru
Nishiguchi, Shuhei
Tamori, Akihiro
Kobayashi, Sawako
Sakaguchi, Hiroki
Shiomi, Susumu
Kim, Soo Ryang
Enomoto, Hirayuki
Saito, Masaki
Imanishi, Hiroyasu
Kawada, Norifumi
[J]. JOURNAL OF GASTROENTEROLOGY, 2013, 48 (03) : 397 - 404
[8] Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B
Masaru Enomoto
Shuhei Nishiguchi
Akihiro Tamori
Sawako Kobayashi
Hiroki Sakaguchi
Susumu Shiomi
Soo Ryang Kim
Hirayuki Enomoto
Masaki Saito
Hiroyasu Imanishi
Norifumi Kawada
[J]. Journal of Gastroenterology, 2013, 48 : 397 - 404
[9] Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
Tseng, Tai-Chung
Yu, Ming-Lung
Liu, Chun-Jen
Lin, Chih-Lin
Huang, Yi-Wen
Hsu, Ching-Sheng
Liu, Chen-Hua
Kuo, Stephanie Fang-Tzu
Pan, Corinna Jen-Hui
Yang, Sheng-Shun
Su, Chien-Wei
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
[J]. ANTIVIRAL THERAPY, 2011, 16 (05) : 629 - 637
[10] Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients
Zhou, Pu
Yang, Feifei
Wang, Jinyu
Mao, Richeng
Qi, Xun
Huang, Yuxian
Zhang, Jiming
[J]. MEDICINE, 2015, 94 (17) : e730

← 1 2 3 4 5 →